Procedures, guidelines and reports
Guidelines for practitioners providing services within the Newborn Metabolic Screening Programme in New Zealand February 2010
Hard copies of these guidelines are available from our Publications Centre on (04) 496 2277, Ministry of Health Publications, Sector Operations Contact Centre, Private Bag 3015, Whanganui 4540, or email [email protected]. Please quote: HP4968
- Guidelines for practitioners providing services within the Newborn Metabolic Screening Programme in New Zealand February 2010
Update August 2020
Key changes have taken place with the Newborn Metabolic Screening Programme since COVID-19 and further changes are planned for the near future.
- Sample test cards will be accepted for processing from 24 hours, although the recommended time is still 48 to 72 hours and as close to 48 hours as is feasible.
- There will be a change of card colour as new cards are printed from buff to white – keep using old buff cards until new white cards are received and the old stock is used up.
- New information will be required on the cards regarding the location where the sample was taken (community or hospital).
- Midwives and hospital staff are to ensure that they are receiving all test results within 10 days of a child’s birth and if not, to check that the lab has the sample using the courier track number and call 0800 LABLINK to enquire about sample/result.
Heel pricks – warming, pain relief and lancet use
This paper provides information on best practice for heel warming, pain relief, and lancet use.
Screening for Fatty Acid Oxidation Disorders in the Newborn Metabolic Screening Programme
This paper provides information about the addition of fatty acid oxidation disorders to the Newborn Metabolic Screening Programme in December 2006.
- Screening for Fatty Acid Oxidation Disorders in the Newborn Metabolic Screening Programme (PDF, 456 KB)
Newborn screening and diagnostic protocol for cystic fibrosis in New Zealand
This paper describes the newborn screening and diagnostic protocol for cystic fibrosis in New Zealand, and was finalised by the NMSP Technical Group in April 2016.
In this section
The Newborn Metabolic Screening Programme Policy Framework provides guidance for all programme providers within the screening programme.
Samples must be taken at or as soon as possible after baby is 48 hours of age provided consent has been obtained from parents or guardians.
The NSU and Ministry of Health recommend that all parents and caregivers are offered newborn metabolic screening for their baby.
Monitoring of screening programmes is required to ensure ongoing quality and an evidence base to service development.